We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Population-Scale Proteomics Study Identifies New Genetic-Protein Links

By LabMedica International staff writers
Posted on 06 Oct 2026

Population-scale proteomics is increasingly used to connect genetic variation, protein biology, and health-related traits in studies of complex human disease. More...

These efforts require both analytical depth and sufficient throughput to process large, diverse cohorts, which remains challenging in large-scale proteomic research. Building on this need, a new integrated proteomics approach combines complementary protein-measurement technologies to uncover previously unreported genetic-protein associations in a Singapore population health study.

In the PRECISE-SG100K study, a strategic collaboration involving Thermo Fisher Scientific, Precision Health Research, Singapore, and Nanyang Technological University, Singapore identified more than 2,500 previously unreported genetic-protein associations. Initial results, presented at the Human Proteome Organization (HUPO) World Congress, were based on analysis of the first 10,000 participant samples and combined Thermo Fisher proteomics technologies with PRECISE-SG100K genomic and health data.

The study integrates Olink Proximity Extension Assay (PEA) platforms with the Orbitrap Astral mass spectrometry system and Seer’s Proteograph Product Suite. The Orbitrap Astral platform supports deep discovery proteomics by measuring thousands of proteins directly at high throughput, while Olink PEA technology provides highly sensitive, targeted protein measurements. Together, these complementary approaches extend proteomic coverage and enable protein findings to be analyzed alongside genomic and health information.

Analysis of approximately 10,000 participant samples quantified about 8,800 protein groups. A genetic association analysis identified more than 4,200 proteins whose levels were linked to nearby genetic differences, including significant cis-protein quantitative trait loci. Among these findings, researchers identified 2,762 associations between genetic variation and protein levels that had not been reported across 12 reference studies used for comparison.

Researchers also linked proteins to 71 health-related traits, demonstrating how the integrated dataset could connect molecular findings with clinically relevant characteristics. These findings included identification and confirmation of the relationship between SOST/sclerostin, a biologically validated osteoporosis target, and bone mineral density. The integrated approach is intended to provide additional evidence for investigating disease pathways, potential biomarkers, and therapeutic targets.

The SG100K study has recruited more than 100,000 participants from Singapore’s diverse, multi-ethnic Asian population. It integrates genomic, proteomic, clinical, and other health information to provide insight into healthy states and disease biology. The study is designed to examine how genetics, environment, and lifestyle influence disease risk and treatment response, while addressing underrepresentation of diverse populations in biomedical and translational research.

Related Links
Nanyang Technological University
Precision Health Research


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.